Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1Endocrine 1CNS 1

Conditions

Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Sarcoma 6Rhabdomyosarcoma 5Prostatic Neoplasms 5Sarcoma, Synovial 3Osteosarcoma 3Neuroectodermal Tumors, Primitive, Peripheral 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Sarcoma, Ewing 2Neoplasm Metastasis 2Lung Neoplasms 2Liposarcoma 2Leiomyosarcoma 2Hemangiosarcoma 2Head and Neck Neoplasms 2Fibrosarcoma 2Colorectal Neoplasms 2Adrenocortical Carcinoma 2Zollinger-Ellison Syndrome 1Wilms Tumor 1Uveal Melanoma 1Unspecified Childhood Solid Tumor, Protocol Specific 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Small Cell Lung Carcinoma 1Retinoblastoma 1Rectal Neoplasms 1Pinealoma 1

Interventions

Carboplatin 26Etoposide 22Vincristine 18Melphalan 14Filgrastim 14Topotecan 11Granulocyte Colony-Stimulating Factor 10Cyclophosphamide 9Thiotepa 7Cryotherapy 6Peripheral Blood Stem Cell Transplantation 4Mesna 4Drug Therapy 4Busulfan 4Radiotherapy 3Ifosfamide 3Doxorubicin 3Temozolomide 2Platinum Compounds 2Eye Enucleation 2Cisplatin 2Brachytherapy 2trioctyl phosphine oxide 1sargramostim 1racotumomab 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1etoposide phosphate 1cixutumumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Retinoblastoma × cixutumumab × Clear all
NCT00831844 2015-03-30

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 2 Completed
116 enrolled 8 charts
CNSEndocrineGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Wilms Tumor, Neuroblastoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Neuroectodermal Tumors, Hepatoblastoma, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡